Lek receives the TOP 10 Education Management Award for the 15th time in a row

  • Lek has ranked itself for the 15th time among the ten best custodians of knowledge in Slovenia. 
  • In 2016, Lek provided its associates with as many as 173,162 hours of education.
  • The award is bestowed by Planet GV and the Education Management Institute Sofos.
19. 10. 2017

Lek Pharmaceuticals d.d. received this year its 15th TOP 10 Education Management Award, ranking itself once again among the ten best custodians of knowledge in Slovenia. Planet GV and the Education Management Institute Sofos bestow this award on ten companies in Slovenia, which in the previous year invested the most intensely and systematically in the education of their employees.

In the past year, Lek employees continued to take part in a large number of education and training sessions; in 2016, the access to new knowledge and skills was enabled and facilitated also by the introduction of a modern, advanced web solution »Skillsoft«, which provides a wide range of resources for personal development and learning. It enables unlimited access to all Lek associates and is available 24/7. »Skillsoft« covers a wide range of contents, from business skills and personal performance to IT skills and managerial skills; the contents are available in various forms, including on-line courses, videos, books and audio books.

In addition to this web solution, the decision was made to introduce a modern e-learning system »SELS« to be used for compulsory education and training. 

»In order to improve the process and minimize disruption to regular work, Lek has decided to switch to a new e-learning system 'SELS' for compulsory education«, explained Fikret Bašanović, organisational learning and development manager at Lek, the reasons for the transformation of the education system. »As a pharmaceutical company, we are committed to quality of our products, therefore we pay a lot of attention to educate the associates with regard to quality (so called GxP training). The organisation of GxP training in the traditional way in the classroom was, due to the large number of employees who attended it annually, very complex. With the introduction of an electronic system, we have simplified and optimised the process.«

The new education system enables more efficient business operation as most employees can undertake education or training in e-form. In this way, the associates can undergo education when it best suits their work schedule, which significantly affects business performance. In 2016, 3,502 Lek employees took part in at least one form of upgrading their knowledge and skills or training; in total they had as many as 173,162 hours of education.

The TOP 10 Awards were presented as part of this year’s Organisational Learning and Development conference, which was held on 19 and 20 October 2017 in Portorož.

* * *

Lek, a Sandoz company, is one of the key pillars of the second-largest generic pharmaceutical company globally. Its role within Sandoz is to act as: a leading global development center for technologically demanding products and technologies; a key global manufacturing center for active pharmaceutical ingredients and medicines; a competence center for the development of vertically integrated products; a Sandoz competence center in the field of development and manufacturing of biosimilar active ingredients and products; a supply center for the markets of Central and Eastern Europe (CEE), South East Europe (SEE) and the Commonwealth of Independent States (CIS), and is responsible for marketing and sales of Sandoz products on the Slovenian market. For further information, please visit www.lek.si.

Sandoz is a global leader in generic and biosimilar pharmaceuticals. As a division of the Novartis Group, our purpose is to discover new ways to improve and extend people’s lives. We contribute to society’s ability to support growing healthcare needs by pioneering novel approaches to help people around the world access high-quality medicine. Our portfolio of approximately 1000 molecules, covering all major therapeutic areas, accounted for 2016 sales of USD 10.1 billion. In 2016, our products reached more than 500 million patients and we aspire to reach one billion. Sandoz is headquartered in Holzkirchen, in Germany’s Greater Munich area.
Sandoz is on Twitter. Sign up to follow @Sandoz_global at http://twitter.com/Sandoz_Global (link is external).

Novartis provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, cost-saving generic and biosimilar pharmaceuticals and eye care. Novartis has leading positions globally in each of these areas. In 2016, the Group achieved net sales of USD 48.5 billion, while R&D throughout the Group amounted to approximately USD 9.0 billion. Novartis Group companies employ approximately 118,000 full-time-equivalent associates. Novartis products are sold in approximately 155 countries around the world. For more information, please visit http://www.novartis.com.

* * *

This press release contains statements and conclusions based on projections of Lek’s future business operations. These estimates are derived from the best information currently available. In case these forecasts prove unreliable, the actual results could prove different from those projected.

- end -

For additional information contact:
Katarina Klemenc
Corporate Communications 
Lek Pharmaceuticals d. d.
Phone: +386 1 580 22 43
Fax: +386 1 580 24 32